Abstract:
PURPOSE: A producing method of a salted pollack roe extract, and a composition containing thereof are provided to obtain the salted pollack roe extract containing abundant amount of conjugated fatty acid. CONSTITUTION: A producing method of a salted pollack roe extract comprises the following steps: washing and assorting pollack roe; soaking the pollack roe in a seasoning solution including 1-30% of salt, 1-30% of seasoning powder, 1-20% of sorbitol, and 1-20% of alcohol; adding red pepper powder, sugar, garlic, and starch syrup to the seasoned pollack roe, and low temperature aging the pollack roe for 1-7 days at 1-20 deg. C; freezing the pollack roe before vacuum freezing; extracting the freeze-dried pollack roe using an organic solvent; and fractionating the obtained extract into an extract and an insoluble extraction residue.
Abstract:
PURPOSE: A composition containing salted-fermented shrimp extract is provided to reduce lipid content in liver tissue and feces. CONSTITUTION: A pharmaceutical composition for preventing and treating obesity, hyperlipidemia and artheriosclerotic vascular diseases contains salted-fermented shrimp powder or polar solvent soluble extract or polar solvent insoluble extract thereof as an active ingredient. The polar solvent soluble extract is prepared using water including purified water, low carbon number alcohol, or mixture solvent thereof. A health food for preventing and treating obesity or hyperlipidemia and arteriosclerotic vascular diseases contains salted-fermented shrimp powder or polar solvent soluble extract or polar solvent insoluble extract thereof as an active ingredient. The health food includes powder, granules, tablets, capsules, or beverage.
Abstract:
PURPOSE: A composition containing deep sea water is provided to reduce neutral fat, cholesterol, phospholipide, and hydroxyl radical and to prevent and treat obesity or hyperlipidemia. CONSTITUTION: A pharmaceutical composition for preventing and treating obesity or hyperlipidemia and arteriosclerotic vascular diseases contains deep sea water as an active ingredient. The deep sea water is collected under 300-1300m from East sea. The arteriosclerotic vascular diseases include artery scleroma, cardiac insufficiency, hypertensive heart disease, arrhythmia, congenital heart disease, myocardial infarction, angina, stroke, or peripheral vascular disease. A health food for preventing and treating obesity and arteriosclerotic vascular diseases contains the deep sea water as an active ingredient. The health food is powder, granule, tablet, capsule, or beverage.
Abstract:
PURPOSE: A composition containing Hizikia fusiforme extract with an antioxidative activity is provided to remove free radical and to be used in a pharmaceutical composition and health food. CONSTITUTION: A pharmaceutical composition for preventing and treating oxidative stress-related diseases contains Hizikia fusiforme extract as an active ingredient. The Hizikia fusiforme extract is a polar solvent extract. A health food for preventing and treating oxidative stress-related diseases contains the Hizikia fusiforme extract as an active ingredient. The health food is used in the form of powder, granule, tablet, capsule, or beverage. A food additive contains the Hizikia fusiforme extract as an active ingredient.
Abstract:
PURPOSE: An antibacterial composition containing Porphyra tenera extract is provided to ensure antibacterial activity against pathogenic bacteria and to prevent and treat bacterial infectious diseases. CONSTITUTION: An antibacterial composition contains Porphyra tenera extract as an active ingredient. The composition has antibacterial activity against Escherichia coli, Bacillus subtilis, Candida albicans, Streptococcus mutans, or Staphylococcus aureus. The extract is isolated using water including purified water, low alcohol of C1-C4, hexane, chloform, methylene chloride, ethyl acetate, glycerin, butylene glycol, or mixture solvent. A pharmaceutical composition for preventing and treating bacterial infectious diseases contains Porphyra tenera extract as an active ingredient. A neutraceutical composition for preventing and treating bacterial infectious diseases contains the Porphyra tenera extract as an active ingredient. The neutraceutical composition is manufactured in the form of powder, granule, tablet, capsule, or beverage.
Abstract:
본 발명은 간 해독 및 항산화 활성을 갖는 조성물에 관한 것으로, 상세하게는 성게의 건조분말, 이의 극성용매 가용 추출물 및 극성용매 불용성 잔사 등을 유효성분으로 함유하는 본 발명의 조성물은, 생체이물질(xenobiotics)의 일종인 브로모벤젠(bromobenzene)에 의한 간 손상에 미치는 영향을 통해 간 해독 및 항산화 활성을 갖는 약학조성물 및 건강기능식품으로 유용하게 이용할 수 있다. 성게, 간 독성, 항산화
Abstract:
PURPOSE: A composition containing salmon fraction for preventing and treating hyperlipidemia and arteriosclerosis is provided to reduce lipid content in feces, serum, and liver tissue. CONSTITUTION: A pharmaceutical composition for preventing and treating hyperlipidemia and arteriosclerosis contains a salmon fraction with anti-obesity and anti-thrombotic effect as an active ingredient. The salmon fraction is obtained by removing intestine, head, tail and bone of whole salmon and extracting with polar solvent. The polar solvent is water, low alcohol of C1-C4 or mixture thereof. A health food for preventing and treating hyperlipidemia and arteriosclerosis contains salmon fraction with anti-obesity and anti-thrombotic effect as an active ingredient. The health food is manufactured in the form of powder, granule, capsule or beverage.
Abstract:
PURPOSE: A producing method of salted walleyed pollack roe using horse radish is provided to improve the measurement result of microorganisms, yeast, and lactobacillus. CONSTITUTION: A producing method of salted walleyed pollack roe using horse radish comprises the following steps: collecting walleyed pollack roe and washing; dipping the walleyed pollack roe in a first seasoning liquid containing salt; removing foreign material from the walleyed pollack roe; mixing the walleyed pollack roe with a second seasoning liquid containing a horse radish extract; and low temperature aging in 0~10deg C for 24~96hours.